Skip to main content
. 2022 Jun 21;40(11):1156–1165. doi: 10.1007/s11604-022-01298-7

Table 2.

Clinical data of patients with focal-type autoimmune pancreatitis (AIP) and pancreatic duct carcinoma (PD)

Focal-type AIP
n = 20 (± SD)
PD
n = 30 (± SD)
p
Age (y) 65.25 ± 9.40 66.87 ± 8.45 0.539
Male/Female 11/9 18/12 0.953
Lesion size (mm) 33.54 ± 13.62 26.96 ± 7.78 0.061
IgG4 > 280 (mg/dl) 8
280≧IgG4≧135 (mg/dl) 7
Narrowing of main pancratic duct on ERP/MRCP 18
Pathological findings 9
Other organ involvement 6
Effectiveness of steroid therapy 15
cT Stagea
T1a 0
T1b 0
T1c 8
T2 22
T3 0
T4 0

ERP endoscopic retrograde pancreatography, MRCP magnetic resonance cholangiopancreatography

aAccording to the 8th edition of the TNM classification of malignant tumors